skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Journals@Ovid Ovid Full Text remover Base de dados/Biblioteca: WK Lippincott Williams & Wilkins–Connect here FIRST to enable access remover ScienceDirect - Connect here FIRST to enable access remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial

Brisbois, T.D. ; de Kock, I.H. ; Watanabe, S.M. ; Mirhosseini, M. ; Lamoureux, D.C. ; Chasen, M. ; MacDonald, N. ; Baracos, V.E. ; Wismer, W.V.

Annals of oncology, 2011-09, Vol.22 (9), p.2086-2093 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Cutaneous ischemia‐reperfusion injury is exacerbated by IL‐36 receptor antagonist deficiency
Cutaneous ischemia‐reperfusion injury is exacerbated by IL‐36 receptor antagonist deficiency
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cutaneous ischemia‐reperfusion injury is exacerbated by IL‐36 receptor antagonist deficiency

Tanaka, Y. ; Iwata, Y. ; Saito, K. ; Fukushima, H. ; Watanabe, S. ; Hasegawa, Y. ; Akiyama, M. ; Sugiura, K.

Journal of the European Academy of Dermatology and Venereology, 2022-02, Vol.36 (2), p.295-304 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
3
Two cases of EGFR mutation-positive lung adenocarcinoma that transformed into squamous cell carcinoma: successful treatment of one case with rociletinib
Two cases of EGFR mutation-positive lung adenocarcinoma that transformed into squamous cell carcinoma: successful treatment of one case with rociletinib
Material Type:
Artigo 		Adicionar ao Meu Espaço

Two cases of EGFR mutation-positive lung adenocarcinoma that transformed into squamous cell carcinoma: successful treatment of one case with rociletinib

Haratani, K. ; Hayashi, H. ; Watanabe, S. ; Kaneda, H. ; Yoshida, T. ; Takeda, M. ; Shimizu, T. ; Nakagawa, K.

Annals of oncology, 2016-01, Vol.27 (1), p.200-202 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
25P Development of new therapeutic drugs for pancreatic cancer targeting choline transporter-like protein 1 (CTL1/SLC44A1)
25P Development of new therapeutic drugs for pancreatic cancer targeting choline transporter-like protein 1 (CTL1/SLC44A1)
Material Type:
Artigo 		Adicionar ao Meu Espaço

25P Development of new therapeutic drugs for pancreatic cancer targeting choline transporter-like protein 1 (CTL1/SLC44A1)

Inazu, M. ; Hirai, K. ; Watanabe, S. ; Nishijima, N. ; Shibata, K. ; Hase, A. ; Gido, R. ; Yamanaka, T.

Annals of oncology, 2020-03, Vol.31, p.S8-S9 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC)
IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC)

Barlesi, F. ; Nishio, M. ; Cobo, M. ; Steele, N. ; Paramonov, V. ; Parente, B. ; Dear, R. ; Berard, H. ; Peled, N. ; Seneviratne, L.C. ; Baldini, E. ; Watanabe, S. ; Goto, K. ; Mendus, D. ; Patel, H. ; Deng, Y. ; Kowanetz, M. ; Hoang, T. ; Lin, W. ; Papadimitrakopoulou, V.A.

Annals of oncology, 2018-10, Vol.29, p.viii743-viii744 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Prolactin induces the production of Th17 and Th1 cytokines/chemokines in murine Imiquimod-induced psoriasiform skin
Prolactin induces the production of Th17 and Th1 cytokines/chemokines in murine Imiquimod-induced psoriasiform skin
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prolactin induces the production of Th17 and Th1 cytokines/chemokines in murine Imiquimod-induced psoriasiform skin

Hau, C.S. ; Kanda, N. ; Tada, Y. ; Shibata, S. ; Sato, S. ; Watanabe, S.

Journal of the European Academy of Dermatology and Venereology, 2014-10, Vol.28 (10), p.1370-1379 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
7
ES25.05 LN Map
ES25.05 LN Map
Material Type:
Artigo 		Adicionar ao Meu Espaço

ES25.05 LN Map

Watanabe, S.

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S92-S93 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
8
Dyschromatosis symmetrica hereditaria with chilblains due to a novel two‐amino‐acid deletion in the double‐stranded RNA‐binding domain of ADAR1
Dyschromatosis symmetrica hereditaria with chilblains due to a novel two‐amino‐acid deletion in the double‐stranded RNA‐binding domain of ADAR1
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dyschromatosis symmetrica hereditaria with chilblains due to a novel two‐amino‐acid deletion in the double‐stranded RNA‐binding domain of ADAR1

Kono, M. ; Suganuma, M. ; Shimada, T. ; Ishikura, Y. ; Watanabe, S. ; Takeichi, T. ; Muro, Y. ; Akiyama, M.

Journal of the European Academy of Dermatology and Venereology, 2018-10, Vol.32 (10), p.e394-e396 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
9
A phase II study of first-line afatinib for patients aged 75 or older with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan study group trial NEJ027
A phase II study of first-line afatinib for patients aged 75 or older with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan study group trial NEJ027
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II study of first-line afatinib for patients aged 75 or older with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan study group trial NEJ027

aiba, T. ; Minegishi, Y. ; Yamaguchi, O. ; Kuyama, S. ; Watanabe, S. ; Usui, K. ; Mori, M. ; Hataji, O. ; Nukiwa, T. ; Morita, S. ; Kobayashi, K. ; Gemma, A.

Annals of oncology, 2018-10, Vol.29, p.viii522-viii523 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
MS11.03 Minimizing Peri-Operative Morbidity with Pneumonectomy
MS11.03 Minimizing Peri-Operative Morbidity with Pneumonectomy
Material Type:
Artigo 		Adicionar ao Meu Espaço

MS11.03 Minimizing Peri-Operative Morbidity with Pneumonectomy

Watanabe, S.

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S176-S177 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (7.281)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (7.289)
  2. Reports  (64)
  3. Anais de Congresso  (12)
  4. Outros  (1)
  5. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1971  (54)
  2. 1971Até1983  (254)
  3. 1984Até1996  (1.097)
  4. 1997Até2010  (2.713)
  5. Após 2010  (3.251)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (7.283)
  2. Japonês  (1.779)
  3. Chinês  (1)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.